Mirae Asset Global ETFs Holdings’s Altimmune ALT Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$235K	Buy	77,292 +24,726	+47%	+$105K	﹤0.01%	2278
2025 Q4	$190K	Buy	52,566 +6,661	+15%	+$29K	﹤0.01%	2375
2025 Q3	$173K	Sell	45,905 -1,443	-3%	-$5.57K	﹤0.01%	2395
2025 Q2	$181K	Sell	47,348 -1,553	-3%	-$8.4K	﹤0.01%	2327
2025 Q1	$247K	Buy	48,901 +2,241	+5%	+$14.2K	﹤0.01%	2217
2024 Q4	$337K	Buy	46,660 +1,540	+3%	+$11.8K	﹤0.01%	2106
2024 Q3	$279K	Buy	45,120 +9,118	+25%	+$61.8K	﹤0.01%	2198
2024 Q2	$237K	Buy	+36,002	New	+$266K	﹤0.01%	2168

Other funds holding ALT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's ALT Position: Q1 2026 in Review

Mirae Asset Global ETFs Holdings increased its Altimmune (ALT) stake by 47% in Q1 2026, buying an estimated $105K and bringing the position to 77,292 shares worth $235K. The position accounts for ﹤0.01% of the portfolio, ranked #2278.

Mirae Asset Global ETFs Holdings first reported a position in ALT in Q2 2024 and has held it in 8 quarters since. The position peaked at $337K in Q4 2024. 173 funds tracked by Wall St. Rank hold ALT as of Q1 2026.

Mirae Asset Global ETFs Holdings held 77,292 shares of Altimmune worth $235K as of Q1 2026.
Mirae Asset Global ETFs Holdings bought 24,726 Altimmune shares in Q1 2026, an estimated $105K.
Altimmune made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q1 2026, its #2278 holding.
Mirae Asset Global ETFs Holdings first reported a position in Altimmune in Q2 2024 and has held it in 8 quarters since.
Mirae Asset Global ETFs Holdings's Altimmune position peaked at $337K in Q4 2024.
173 funds tracked by Wall St. Rank held Altimmune as of Q1 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q1 2026, filed 15 May 2026.